04522nam 2200661 450 991078882700332120200520144314.03-11-039535-53-11-034146-810.1515/9783110341461(CKB)3360000000515139(MiAaPQ)EBC4749684(DE-B1597)245683(OCoLC)984688419(DE-B1597)9783110341461(Au-PeEL)EBL4749684(CaPaEBR)ebr11366012(OCoLC)980818592(PPN)261973479(EXLCZ)99336000000051513920170405h20172017 uy 0gerurcnu||||||||rdacontentrdamediardacarrierGrammatik des Deutschen im europäischen VergleichTeilband 1Funktionale Domänen, Wort und Wortklassen das Nominal /Lutz Gunkel [and four others] ; unter Mitarbeit von Christine Günther und Ursula Hoberg2 Bd., 2004 S. inges.Berlin, [Germany] ;Boston, [Massachusetts] :De Gruyter,2017.©20171 online resource (1,974 pages)Schriften des Instituts für Deutsche Sprache,1861-566X ;Band 14.13-11-034135-2 Includes bibliographical references and indexes.Frontmatter -- Vorwort -- Inhaltsübersicht -- Verzeichnis der Abkürzungen -- Verzeichnis der Sprachsiglen -- Verzeichnis der Symbole -- Einleitung -- A. Funktionale Domänen -- B1.1 Überblick -- B1.2 Artikel und Demonstrativa -- B1.3 Adjektive -- B1.4 Substantive -- B1.5 Pronomina -- B2.1 Überblick -- B2.2 Genus -- B2.3 Numerus -- B2.4 Kasus -- C. Nominalflexion -- D1. Syntax der Nominalphrase -- D2. Nominalphrasen mit adjektivischem oder partizipialem Kopf -- D3. Possessive Attribute -- D4. Nicht-possessive PP- und NP-Attribute -- D5. Numerativkonstruktionen -- D6. Relativsyntagmen -- D7. Partizipialattribute -- Inhaltsverzeichnis -- Quellenverzeichnis -- Literaturverzeichnis -- Register Das Deutsche gehört zu den besonders gut erforschten Sprachen der Welt. Neue Erkenntnisse über seine Grammatik sind am ehesten durch eine Ausweitung der Perspektive über den traditionellen Ansatz hinaus zu erwarten. Im vorliegenden Handbuch zur Nominalgrammatik geschieht dies auf dem Weg des Sprachvergleichs mit anderen europäischen Sprachen, in erster Linie den Kontrastsprachen Englisch, Französisch, Polnisch und Ungarisch. Die Grammatik schließt an die typologische Forschung an und orientiert den Vergleich an allgemeinen semantisch-pragmatischen Funktionsbereichen, so genannten ,funktionalen Domänen‘ wie Referenz, Identifikation, Modifikation. Behandelt werden nominale Wortklassen (wie Substantiv, Adjektiv, Pronomen), das nominale Klassifikationssystem (mit Genus, Numerus und Kasus), die nominale Flexionsmorphologie sowie nominale Syntagmen mit dem Schwerpunkt der NP-Syntax. Der Vergleich stellt die Optionen im Vergleichsspektrum heraus, von denen das Deutsche Gebrauch macht, zeigt aber auch, welche Möglichkeiten nicht realisiert sind, und lässt somit das typologische Profil dieser Sprache im Detail erkennen. This functionally oriented contrastive grammar is devoted to nominal word classes (such as nouns, adjectives, and pronouns), their classification (such as gender, case, and number), nominal inflectional morphology, and nominal syntagms, especially the syntax of the nominal phrase. The descriptive focus is on German, and the principal contrastive languages are English, French, Polish, and Hungarian. Schriften des Instituts für Deutsche Sprache ;Band 14.1.German languageNounGerman languageGrammar, ComparativeContrastive Linguistics.German Grammar.Grammatical Structures.German languageNoun.German languageGrammar, Comparative.435GC 6009rvkGunkel Lutz, authttp://id.loc.gov/vocabulary/relators/aut506240Gunkel LutzGünther Christine1981-Hoberg UrsulaMiAaPQMiAaPQMiAaPQBOOK9910788827003321Grammatik des Deutschen im europäischen Vergleich3764920UNINA06361nam 22008895 450 991029826790332120220727194510.03-319-20825-X10.1007/978-3-319-20825-1(CKB)3710000000479184(EBL)4178347(SSID)ssj0001583189(PQKBManifestationID)16258188(PQKBTitleCode)TC0001583189(PQKBWorkID)14861988(PQKB)10842333(DE-He213)978-3-319-20825-1(MiAaPQ)EBC4178347(PPN)190532556(EXLCZ)99371000000047918420150925d2015 u| 0engur|n#---|||||txtccrEndocannabinoids /edited by Roger G. Pertwee1st ed. 2015.Cham :Springer International Publishing :Imprint: Springer,2015.1 online resource (477 p.)Handbook of Experimental Pharmacology,0171-2004 ;231Description based upon print version of record.3-319-20824-1 Includes bibliographical references at the end of each chapters and index.Preface; The Endocannabinoid System: A Look Back and Ahead; Contents; Endocannabinoids and Their Pharmacological Actions; 1 Introduction; 2 Evidence That Certain Endogenous Compounds Target Cannabinoid Receptors Orthosterically; 2.1 Evidence from Binding Assays; 2.2 Evidence from Two Functional Bioassays; 2.2.1 [35S]GTPgammaS Binding Assay; 2.2.2 Cyclic AMP Assay; 3 Non-Cannabinoid Receptors and Channels Targeted by Endogenous Cannabinoid Receptor Ligands at Submicromolar Concentrations; 3.1 Non-Cannabinoid G Protein-Coupled Receptors; 3.1.1 GPR55; 3.2 Ligand-Gated Ion Channels3.2.1 5-HT3 Receptors3.2.2 Nicotinic Acetylcholine Receptors; 3.2.3 Glycine Receptors; 3.2.4 Ionotropic Glutamate NMDA Receptors; 3.3 Transient Receptor Potential Channels; 3.3.1 TRPV1; 3.3.2 TRPM8 Channels; 3.4 Voltage-Gated Calcium Channels; 3.4.1 T-Type Cav3 Calcium Channels; 3.5 Potassium Channels; 3.5.1 ATP-Sensitive Inward Rectifier KATP Channels of the 2TM Domain Family; 3.5.2 Voltage-Gated Kv and KCa Channels of the 6TM Domain Family; 4 Allosteric Endocannabinoids; 5 Conclusions; References; Biosynthesis and Fate of Endocannabinoids1 Endocannabinoids and Endocannabinoid-Like Compounds2 Biosynthesis of the Endocannabinoids; 3 Uptake of the Endocannabinoids: Proposed Mechanisms; 4 Degradation of the Endocannabinoids; 4.1 FAAH and NAAA; 4.2 MGL, ABHD6 and ABHD12; 5 Conclusions; References; Distribution of the Endocannabinoid System in the Central Nervous System; 1 Introduction; 1.1 Overview; 1.2 Cells Expressing Components of the ECS; 1.3 Subcellular Localization of CB1 Cannabinoid Receptors; 2 Retina; 2.1 Receptors; 2.2 Synthetic Enzymes; 2.3 Degradative Enzymes; 3 Cerebral Cortex; 3.1 Neocortex; 3.1.1 Receptors3.1.2 Synthetic Enzymes3.1.3 Degradative Enzymes; 3.2 Olfactory Areas (Olfactory Bulb, Piriform Cortex, Associated Regions); 3.2.1 Receptors; 3.2.2 Synthetic Enzymes; 3.2.3 Degradative Enzymes; 3.3 Hippocampal Formation; 3.3.1 Receptors; 3.3.2 Synthetic Enzymes; 3.3.3 Degradative Enzymes; 3.4 Cortical Subplate (Other Amygdala Nuclei); 3.4.1 Receptors; 3.4.2 Synthetic Enzymes; 3.4.3 Degradative Enzymes; 4 Subcortical Nuclei (Striatum, Basal Ganglia); 4.1 Striatum (Dorsal, Caudate); 4.1.1 Receptors; 4.1.2 Synthetic Enzymes; 4.1.3 Degradative Enzymes; 4.2 Striatum (Ventral, Accumbens)4.2.1 Receptors4.2.2 Synthetic Enzymes; 4.2.3 Degradative Enzymes; 4.3 Striatum Medial (Lateral Septum, Septohippocampal, etc.); 4.3.1 Receptors; 4.3.2 Synthetic Enzymes; 4.3.3 Degradative Enzymes; 4.4 Striatum Caudal (Striatum-like Amygdala Nuclei, Central Amygdala, Bed Nucleus, Medial Amygdala, Etc.); 4.4.1 Receptors; 5 Cerebellum and Associated Nuclei; 5.1 Cerebellar Cortex; 5.1.1 Receptors; 5.1.2 Synthetic Enzymes; 5.1.3 Degradative Enzymes; 5.2 Deep Cerebellar Nuclei (Fastigial, Interpos, Dentate Nucleus); 5.2.1 Receptors; 5.2.2 Synthetic Enzymes; 5.2.3 Degradative Enzymes; 6 Brainstem6.1 DiencephalonThere is currently considerable interest in the development of medicines that would enhance endocannabinoid-induced “autoprotection”, for example through inhibition of endocannabinoid metabolizing enzymes or cellular uptake processes or that would oppose endocannabinoid-induced “autoimpairment”. This volume describes the physiology, pathophysiology and pharmacology of the endocannabinoid system and potential strategies for targeting this system in the clinic.Handbook of Experimental PharmacologyPharmacologyCytologyNeurosciencesPsychopharmacologyImmunologyCytokinesGrowth factorsPharmacology/Toxicologyhttps://scigraph.springernature.com/ontologies/product-market-codes/B21007Cell Biologyhttps://scigraph.springernature.com/ontologies/product-market-codes/L16008Neuroscienceshttps://scigraph.springernature.com/ontologies/product-market-codes/B18006Psychopharmacologyhttps://scigraph.springernature.com/ontologies/product-market-codes/H53010Immunologyhttps://scigraph.springernature.com/ontologies/product-market-codes/B14000Cytokines and Growth Factorshttps://scigraph.springernature.com/ontologies/product-market-codes/L14120Pharmacology.Cytology.Neurosciences.Psychopharmacology.Immunology.Cytokines.Growth factors.Pharmacology/Toxicology.Cell Biology.Neurosciences.Psychopharmacology.Immunology.Cytokines and Growth Factors.615.7827Pertwee R. G(Roger G.),edthttp://id.loc.gov/vocabulary/relators/edtMiAaPQMiAaPQMiAaPQBOOK9910298267903321Endocannabinoids1383799UNINA